In another study performed on the colorectal adenocarcinoma cell line, HT-29, to compare the effect of doxycycline with cisplatin and oxaliplatin, it was observed that the tetracycline derivative activates caspase-3 in a manner similar to classical chemotherapeutics [36]. Here, CASP3 is linked to colorectal adenocarcinoma.